Fluid and coating equipment company Graco (NYSE:GGG) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.3% year on year to $528.3 million. Its non-GAAP profit of $0.70 per share was 3.9% above analysts’ consensus estimates.
Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales were flat year on year at $10.36 billion. Its non-GAAP profit of $5.15 per share was 0.9% above analysts’ consensus estimates. The stock remained flat at $433.50 following the earnings release and call.
Medical device company Penumbra (NYSE:PEN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 16.3% year on year to $324.1 million. The company expects the full year’s revenue to be around $1.35 billion, close to analysts’ estimates. Its non-GAAP profit of $0.83 per share was 24.4% above analysts’ consensus estimates.
Freight delivery company Knight-Swift Transportation (NYSE:KNX) beat Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $1.82 billion. Its non-GAAP profit of $0.28 per share was 18.7% above analysts’ consensus estimates.
While gold and gold miners remain strong, both are stretched, and now may be a time to protect gains, especially as broader market internals remain broken.
Premium cinema technology company IMAX (NYSE:IMAX) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.5% year on year to $86.67 million. Its GAAP profit of $0.04 per share was $0.01 below analysts’ consensus estimates.
Racing, gaming, and entertainment company Churchill Downs (NASDAQ:CHDN) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.7% year on year to $642.6 million. Its non-GAAP profit of $1.07 per share was 3.5% above analysts’ consensus estimates.
IT services provider ASGN (NYSE:ASGN) announced better-than-expected revenue in Q1 CY2025, but sales fell by 7.7% year on year to $968.3 million. On the other hand, next quarter’s revenue guidance of $1 billion was less impressive, coming in 1.1% below analysts’ estimates. Its non-GAAP profit of $0.92 per share was 2.6% below analysts’ consensus estimates.
Freight and logistics provider Covenant Logistics (NASDAQ:CVLG) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.4% year on year to $269.4 million. Its non-GAAP profit of $0.32 per share was 5% below analysts’ consensus estimates.
Defense, intelligence, and IT solutions provider CACI International (NYSE:CACI) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 11.8% year on year to $2.17 billion. The company expects the full year’s revenue to be around $8.6 billion, close to analysts’ estimates. Its non-GAAP profit of $6.23 per share was 11.3% above analysts’ consensus estimates.
Healthcare services company Chemed Corporation (NYSE:CHE) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.8% year on year to $646.9 million. Its non-GAAP profit of $5.63 per share was 1.5% above analysts’ consensus estimates.
